Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Asian J Surg ; 45(1): 339-345, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34148748

ABSTRACT

BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) are increasingly utilised in the management of colorectal peritoneal metastases (CPM). This combined modality is associated with a significant learning curve (LC) and is often criticised for its associated morbidity. This study aims to inspect the LC of this procedure in our institute. METHODS: A retrospective review of the institution's prospectively maintained database of CRS-HIPEC cases was performed. Patients treated for CPM were stratified into two groups: Group 1 consists of patients in our initial 100 cases of CRS-HIPEC and Group 2 comprises patients treated subsequently. Perioperative prognostic factors and oncological outcomes were analysed. RESULTS: Between 2001 and 2016, 77 patients with CPM underwent CRS-HIPEC, of which 31 patients (40.3%) were in Group 1 and 46 patients (59.7%) in Group 2. Median follow-up duration was 96 months in Group 1 and 25 months in Group 2. There were no differences in OS (35 months vs 46 months, p = 0.054) and DFS (13 months vs 14 months, p = 0.676) between the groups. There were more patients with higher PCI (≥12) (57.1% vs 22.2%, p = 0.006) and high-grade complications (25.8% vs 8.7%, p = 0.045) in Group 1. Group 2 patients had a shorter hospitalisation (14 days vs 11 days, p = 0.015) and SICU stay (1 day vs 0 days, p < 0.001). CONCLUSION: An improvement in the perioperative outcomes after CRS-HIPEC for CPM may be partly attributed to overcoming the LC and incorporation of better patient selection methods.


Subject(s)
Colorectal Neoplasms , Hyperthermia, Induced , Percutaneous Coronary Intervention , Peritoneal Neoplasms , Antineoplastic Combined Chemotherapy Protocols , Colorectal Neoplasms/therapy , Combined Modality Therapy , Cytoreduction Surgical Procedures , Humans , Hyperthermic Intraperitoneal Chemotherapy , Learning Curve , Peritoneal Neoplasms/therapy , Retrospective Studies , Survival Rate
2.
Asian J Surg ; 39(2): 125, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27466637
3.
Asian J Surg ; 39(1): 45-7, 2016 Jan.
Article in English | MEDLINE | ID: mdl-24637188

ABSTRACT

The colon can be used for esophageal reconstruction after an esophagectomy. The development of a malignancy in the colonic interposition graft is rare, with less than 15 cases reported in the literature. We present a case of a 60-year-old male with high-grade dysplasia of the colonic interposition graft used for reconstruction of the esophagus, which developed 41 years after the esophageal reconstruction. The long-term complication of the development of a malignancy must be considered when using the colon for reconstruction especially when the esophageal reconstruction is performed for a benign cause.


Subject(s)
Colon/transplantation , Colonic Neoplasms/diagnostic imaging , Esophagectomy , Postoperative Complications/diagnostic imaging , Colonic Neoplasms/pathology , Colonic Neoplasms/surgery , Humans , Male , Middle Aged , Positron Emission Tomography Computed Tomography , Postoperative Complications/pathology , Postoperative Complications/surgery
4.
Asian J Surg ; 38(2): 65-73, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25059814

ABSTRACT

INTRODUCTION: Compared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been shown to improve survival in patients with recurrent colorectal disease confined to the peritoneum. We report our experience with CRS and HIPEC for colorectal cancer patients with peritoneal carcinomatosis, evaluating prognostic factors for disease-free survival (DFS), overall survival (OS), and perioperative morbidity and mortality. METHODS: All patients who underwent CRS and HIPEC were included in our study. Clinical characteristics, operative data, and 30-day morbidity and mortality were collected and evaluated. RESULTS: Between January 2001 and December 2012, there were 35 consecutive patients who underwent CRS and HIPEC at our institution. Thirty-three patients (94%) had optimal cytoreduction. No 30-day mortality was reported, but 14 patients had postoperative complications. The median DFS was 9.4 months (95% confidence interval 5.5-18.7 months), and DFS at 1 year, 3 years, and 5 years were 43.8%, 22.3%, and 22.3%, respectively. The median OS was calculated to be 27.1 months (95% confidence interval 15.3-39.1), and the OS at 1 year, 3 years, and 5 years were 83.7%, 38.2%, and 19.1%, respectively. CONCLUSION: CRS and HIPEC can provide survival benefit, with reasonable morbidity and mortality for Asian patients with peritoneal carcinomatosis from colorectal cancer. Patient selection and perioperative management of the patients are key to the success of the procedure.


Subject(s)
Carcinoma/secondary , Chemotherapy, Cancer, Regional Perfusion/methods , Colorectal Neoplasms/pathology , Cytoreduction Surgical Procedures , Hyperthermia, Induced , Peritoneal Neoplasms/secondary , Adolescent , Adult , Aged , Antibiotics, Antineoplastic/administration & dosage , Antibiotics, Antineoplastic/therapeutic use , Carcinoma/mortality , Carcinoma/therapy , Colorectal Neoplasms/mortality , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Mitomycin/administration & dosage , Mitomycin/therapeutic use , Peritoneal Neoplasms/mortality , Peritoneal Neoplasms/therapy , Postoperative Complications/epidemiology , Singapore , Survival Analysis , Tertiary Care Centers , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...